These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27282513)

  • 1. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.
    Kumar PS; Pallera HK; Hair PS; Rivera MG; Shah TA; Werner AL; Lattanzio FA; Cunnion KM; Krishna NK
    Transfusion; 2016 Aug; 56(8):2133-45. PubMed ID: 27282513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
    Shah TA; Mauriello CT; Hair PS; Sharp JA; Kumar PS; Lattanzio FA; Werner AL; Whitley PH; Maes LA; Cunnion KM; Krishna NK
    Transfusion; 2014 Nov; 54(11):2892-900. PubMed ID: 24806146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.
    Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY
    Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.
    Sharp JA; Hair PS; Pallera HK; Kumar PS; Mauriello CT; Nyalwidhe JO; Phelps CA; Park D; Thielens NM; Pascal SM; Chen W; Duffy DM; Lattanzio FA; Cunnion KM; Krishna NK
    PLoS One; 2015; 10(7):e0132446. PubMed ID: 26196285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incompatible erythrocyte transfusion with lipopolysaccharide induces acute lung injury in a novel rat model.
    Gregory Rivera M; Sampson AC; Hair PS; Pallera HK; Jackson KG; Enos AI; Vazifedan T; Werner AL; Goldberg CL; Lattanzio FA; Cunnion KM; Krishna NK
    PLoS One; 2020; 15(4):e0230482. PubMed ID: 32310973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C
    Goggs R; Behling-Kelly E
    BMC Vet Res; 2019 Dec; 15(1):475. PubMed ID: 31888626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
    Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
    Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
    Brixner V; Kiessling AH; Madlener K; Müller MM; Leibacher J; Dombos S; Weber I; Pfeiffer HU; Geisen C; Schmidt M; Henschler R; North A; Huang N; Mufti N; Erickson A; Ernst C; Rico S; Benjamin RJ; Corash LM; Seifried E
    Transfusion; 2018 Apr; 58(4):905-916. PubMed ID: 29498049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet light and riboflavin accelerates red blood cell dysfunction in vitro and in a guinea pig transfusion model.
    Baek JH; Shin HKH; Xu F; Zhang X; Williams MC; Gao Y; Vostal JG; Buehler PW; Villa C; D'Agnillo F
    Blood Transfus; 2024 Jul; 22(4):316-327. PubMed ID: 38814883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report.
    Hair PS; Heck TP; Carr DT; Watson KD; Price J; Krishna NK; Cunnion KM; Owen WC
    J Hematol; 2021 Feb; 10(1):18-21. PubMed ID: 33643505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of haemolytic transfusion reactions.
    Webster BH
    Anaesth Intensive Care; 1980 May; 8(2):115-9. PubMed ID: 7396174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT).
    Gregory Rivera M; Hair PS; Cunnion KM; Krishna NK
    PLoS One; 2018; 13(3):e0193931. PubMed ID: 29499069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-complement effect of bilirubin-IXalpha.
    Arriaga S; Almará A; Mottino A
    Biochem Pharmacol; 2002 Aug; 64(4):741-4. PubMed ID: 12167493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.
    Osei-Hwedieh DO; Kanias T; Croix CS; Jessup M; Xiong Z; Sinchar D; Franks J; Xu Q; M Novelli E; Sertorio JT; Potoka K; Binder RJ; Basu S; Belanger AM; Kim-Shapiro DB; Triulzi D; Lee JS; Gladwin MT
    EBioMedicine; 2016 Sep; 11():239-248. PubMed ID: 27523807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.
    Sharp JA; Whitley PH; Cunnion KM; Krishna NK
    Front Immunol; 2014; 5():406. PubMed ID: 25202312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.